A. Damjanović
Oncology · 2019
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 18 citations into it
Whom A. Damjanović trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- F. Sharom (in Oncology)
Papers from A. Damjanović's perspective
Ordered by how strongly the researchers A. Damjanović trusts endorse each paper. Same corpus, a different order for every researcher.
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications (Proceedings of the National Academy of Sciences of the United States of America)
- Molecular portraits of human breast tumours (Nature)
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. (Journal of Clinical Investigation)
- Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. (Journal of Clinical Oncology)
- Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence (Clinical Cancer Research)
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation (New England Journal of Medicine)
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (Ca)
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features (Proceedings of the National Academy of Sciences of the United States of America)
- Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. (Cancer Research)
- A randomised phase III trial of carboplatin compared with docetaxel in BRCA1/2 mutated and pre-specified triple negative breast cancer “BRCAness” subgroups: the TNT Trial (Nature Medicine)